AstraZeneca said that it had developed a vaccine platform to respond quickly to new variants with Oxford University, where its vaccine was created.
Omicron variant: AstraZeneca exploring impact on vaccine, antibody cocktail
AstraZeneca said that it had developed a vaccine platform to respond quickly to new variants with Oxford University, where its vaccine was created.